The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Totally Implantable Intravenous Device (TIVAD) Market Research Report 2025
Synopsis
The totally implantable venous access deviceis a blood vessel or thoracoabdominal access device that is completely implanted in the body, which can reduce the pain and risk of repeated vein, artery, thoracoabdominal puncture.
Global Totally Implantable Intravenous Device (TIVAD) market is projected to reach US$ 205.8 million in 2029, increasing from US$ 137.8 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Totally Implantable Intravenous Device (TIVAD) market research.
Totally Implantable Intravenous Device (TIVAD) market had been witnessing steady growth. TIVADs are medical devices that are implanted under the skin to provide long-term intravenous access for patients who require frequent or continuous administration of medications, fluids, or blood products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Totally Implantable Intravenous Device (TIVAD) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
C.R. Bard
AngioDynamics
Smiths Medical
Bard Access Systems
B. Braun
Teleflex
Cook Medical
Fresenius Kabi
PFM Medical
Vygon
Districlass
PakuMed
MedComp
Navilyst Medical
Norfolk Medical Products
Suzhou Linhwa Medical Devices
Weigao Holding
Guangdong Baihe Medical Technology
Segment by Type
Titanium Port Body
Plastic Port Body
Segment by Application
Cancer
End-Stage Renal Disease
Diabetes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Totally Implantable Intravenous Device (TIVAD) report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The totally implantable venous access deviceis a blood vessel or thoracoabdominal access device that is completely implanted in the body, which can reduce the pain and risk of repeated vein, artery, thoracoabdominal puncture.
Global Totally Implantable Intravenous Device (TIVAD) market is projected to reach US$ 205.8 million in 2029, increasing from US$ 137.8 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Totally Implantable Intravenous Device (TIVAD) market research.
Totally Implantable Intravenous Device (TIVAD) market had been witnessing steady growth. TIVADs are medical devices that are implanted under the skin to provide long-term intravenous access for patients who require frequent or continuous administration of medications, fluids, or blood products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Totally Implantable Intravenous Device (TIVAD) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
C.R. Bard
AngioDynamics
Smiths Medical
Bard Access Systems
B. Braun
Teleflex
Cook Medical
Fresenius Kabi
PFM Medical
Vygon
Districlass
PakuMed
MedComp
Navilyst Medical
Norfolk Medical Products
Suzhou Linhwa Medical Devices
Weigao Holding
Guangdong Baihe Medical Technology
Segment by Type
Titanium Port Body
Plastic Port Body
Segment by Application
Cancer
End-Stage Renal Disease
Diabetes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Totally Implantable Intravenous Device (TIVAD) report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Totally Implantable Intravenous Device (TIVAD) Market Overview
1.1 Product Overview and Scope of Totally Implantable Intravenous Device (TIVAD)
1.2 Totally Implantable Intravenous Device (TIVAD) Segment by Type
1.2.1 Global Totally Implantable Intravenous Device (TIVAD) Market Value Comparison by Type (2023-2029)
1.2.2 Titanium Port Body
1.2.3 Plastic Port Body
1.3 Totally Implantable Intravenous Device (TIVAD) Segment by Application
1.3.1 Global Totally Implantable Intravenous Device (TIVAD) Market Value by Application: (2023-2029)
1.3.2 Cancer
1.3.3 End-Stage Renal Disease
1.3.4 Diabetes
1.4 Global Totally Implantable Intravenous Device (TIVAD) Market Size Estimates and Forecasts
1.4.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue 2018-2029
1.4.2 Global Totally Implantable Intravenous Device (TIVAD) Sales 2018-2029
1.4.3 Global Totally Implantable Intravenous Device (TIVAD) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Totally Implantable Intravenous Device (TIVAD) Market Competition by Manufacturers
2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Totally Implantable Intravenous Device (TIVAD) Average Price by Manufacturers (2018-2023)
2.4 Global Totally Implantable Intravenous Device (TIVAD) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Totally Implantable Intravenous Device (TIVAD), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Totally Implantable Intravenous Device (TIVAD), Product Type & Application
2.7 Totally Implantable Intravenous Device (TIVAD) Market Competitive Situation and Trends
2.7.1 Totally Implantable Intravenous Device (TIVAD) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Totally Implantable Intravenous Device (TIVAD) Players Market Share by Revenue
2.7.3 Global Totally Implantable Intravenous Device (TIVAD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Totally Implantable Intravenous Device (TIVAD) Retrospective Market Scenario by Region
3.1 Global Totally Implantable Intravenous Device (TIVAD) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Totally Implantable Intravenous Device (TIVAD) Global Totally Implantable Intravenous Device (TIVAD) Sales by Region: 2018-2029
3.2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Region: 2018-2023
3.2.2 Global Totally Implantable Intravenous Device (TIVAD) Sales by Region: 2024-2029
3.3 Global Totally Implantable Intravenous Device (TIVAD) Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region: 2018-2029
3.3.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region: 2018-2023
3.3.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region: 2024-2029
3.4 North America Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
3.4.1 North America Totally Implantable Intravenous Device (TIVAD) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2018-2029)
3.4.3 North America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
3.5.1 Europe Totally Implantable Intravenous Device (TIVAD) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Totally Implantable Intravenous Device (TIVAD) Sales by Country (2018-2029)
3.5.3 Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
3.6.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Country (2018-2029)
3.6.3 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
3.7.1 Latin America Totally Implantable Intravenous Device (TIVAD) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2018-2029)
3.7.3 Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
3.8.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Type (2018-2029)
4.1.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Type (2018-2023)
4.1.2 Global Totally Implantable Intravenous Device (TIVAD) Sales by Type (2024-2029)
4.1.3 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2018-2029)
4.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2018-2029)
4.2.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2018-2023)
4.2.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2024-2029)
4.2.3 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2018-2029)
4.3 Global Totally Implantable Intravenous Device (TIVAD) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Application (2018-2029)
5.1.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Application (2018-2023)
5.1.2 Global Totally Implantable Intravenous Device (TIVAD) Sales by Application (2024-2029)
5.1.3 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2018-2029)
5.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2018-2029)
5.2.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2018-2023)
5.2.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2024-2029)
5.2.3 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2018-2029)
5.3 Global Totally Implantable Intravenous Device (TIVAD) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 C.R. Bard
6.1.1 C.R. Bard Corporation Information
6.1.2 C.R. Bard Description and Business Overview
6.1.3 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.1.5 C.R. Bard Recent Developments/Updates
6.2 AngioDynamics
6.2.1 AngioDynamics Corporation Information
6.2.2 AngioDynamics Description and Business Overview
6.2.3 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.2.5 AngioDynamics Recent Developments/Updates
6.3 Smiths Medical
6.3.1 Smiths Medical Corporation Information
6.3.2 Smiths Medical Description and Business Overview
6.3.3 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.3.5 Smiths Medical Recent Developments/Updates
6.4 Bard Access Systems
6.4.1 Bard Access Systems Corporation Information
6.4.2 Bard Access Systems Description and Business Overview
6.4.3 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.4.5 Bard Access Systems Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B. Braun Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Teleflex
6.6.1 Teleflex Corporation Information
6.6.2 Teleflex Description and Business Overview
6.6.3 Teleflex Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teleflex Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.6.5 Teleflex Recent Developments/Updates
6.7 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cook Medical Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.7.5 Cook Medical Recent Developments/Updates
6.8 Fresenius Kabi
6.8.1 Fresenius Kabi Corporation Information
6.8.2 Fresenius Kabi Description and Business Overview
6.8.3 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.8.5 Fresenius Kabi Recent Developments/Updates
6.9 PFM Medical
6.9.1 PFM Medical Corporation Information
6.9.2 PFM Medical Description and Business Overview
6.9.3 PFM Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 PFM Medical Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.9.5 PFM Medical Recent Developments/Updates
6.10 Vygon
6.10.1 Vygon Corporation Information
6.10.2 Vygon Description and Business Overview
6.10.3 Vygon Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Vygon Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.10.5 Vygon Recent Developments/Updates
6.11 Districlass
6.11.1 Districlass Corporation Information
6.11.2 Districlass Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
6.11.3 Districlass Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Districlass Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.11.5 Districlass Recent Developments/Updates
6.12 PakuMed
6.12.1 PakuMed Corporation Information
6.12.2 PakuMed Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
6.12.3 PakuMed Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 PakuMed Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.12.5 PakuMed Recent Developments/Updates
6.13 MedComp
6.13.1 MedComp Corporation Information
6.13.2 MedComp Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
6.13.3 MedComp Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.13.4 MedComp Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.13.5 MedComp Recent Developments/Updates
6.14 Navilyst Medical
6.14.1 Navilyst Medical Corporation Information
6.14.2 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
6.14.3 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.14.5 Navilyst Medical Recent Developments/Updates
6.15 Norfolk Medical Products
6.15.1 Norfolk Medical Products Corporation Information
6.15.2 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
6.15.3 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.15.5 Norfolk Medical Products Recent Developments/Updates
6.16 Suzhou Linhwa Medical Devices
6.16.1 Suzhou Linhwa Medical Devices Corporation Information
6.16.2 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
6.16.3 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.16.5 Suzhou Linhwa Medical Devices Recent Developments/Updates
6.17 Weigao Holding
6.17.1 Weigao Holding Corporation Information
6.17.2 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
6.17.3 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.17.5 Weigao Holding Recent Developments/Updates
6.18 Guangdong Baihe Medical Technology
6.18.1 Guangdong Baihe Medical Technology Corporation Information
6.18.2 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
6.18.3 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Product Portfolio
6.18.5 Guangdong Baihe Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Totally Implantable Intravenous Device (TIVAD) Industry Chain Analysis
7.2 Totally Implantable Intravenous Device (TIVAD) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Totally Implantable Intravenous Device (TIVAD) Production Mode & Process
7.4 Totally Implantable Intravenous Device (TIVAD) Sales and Marketing
7.4.1 Totally Implantable Intravenous Device (TIVAD) Sales Channels
7.4.2 Totally Implantable Intravenous Device (TIVAD) Distributors
7.5 Totally Implantable Intravenous Device (TIVAD) Customers
8 Totally Implantable Intravenous Device (TIVAD) Market Dynamics
8.1 Totally Implantable Intravenous Device (TIVAD) Industry Trends
8.2 Totally Implantable Intravenous Device (TIVAD) Market Drivers
8.3 Totally Implantable Intravenous Device (TIVAD) Market Challenges
8.4 Totally Implantable Intravenous Device (TIVAD) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
